The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways

Cervical cancer is one of the most common and lethal cancers among women worldwide. Treatment options are limited in patients with persistent, recurrent, or metastatic cervical cancer, with <20% of women living >5 years. Persistent human papillomavirus (HPV) infection has been implicated in al...

Descripción completa

Detalles Bibliográficos
Autores principales: Birrer, Michael J., Fujiwara, Keiichi, Oaknin, Ana, Randall, Leslie, Ojalvo, Laureen S., Valencia, Christian, Ray-Coquard, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905681/
https://www.ncbi.nlm.nih.gov/pubmed/35280818
http://dx.doi.org/10.3389/fonc.2022.814169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905681/
https://www.ncbi.nlm.nih.gov/pubmed/35280818
http://dx.doi.org/10.3389/fonc.2022.814169

Ejemplares similares